Cargando…
Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450331/ https://www.ncbi.nlm.nih.gov/pubmed/25885428 http://dx.doi.org/10.1038/bcj.2015.33 |
| _version_ | 1782373993808920576 |
|---|---|
| author | Tao, T Ma, X Yang, J Zou, J-Y Ji, S-M Tan, Y-S Gong, W Du, F Xu, J Ye, C-M Tang, X-W Wu, D-P Xue, S-L |
| author_facet | Tao, T Ma, X Yang, J Zou, J-Y Ji, S-M Tan, Y-S Gong, W Du, F Xu, J Ye, C-M Tang, X-W Wu, D-P Xue, S-L |
| author_sort | Tao, T |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4450331 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44503312015-06-09 Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients Tao, T Ma, X Yang, J Zou, J-Y Ji, S-M Tan, Y-S Gong, W Du, F Xu, J Ye, C-M Tang, X-W Wu, D-P Xue, S-L Blood Cancer J Letter to the Editor Nature Publishing Group 2015-04 2015-04-17 /pmc/articles/PMC4450331/ /pubmed/25885428 http://dx.doi.org/10.1038/bcj.2015.33 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Tao, T Ma, X Yang, J Zou, J-Y Ji, S-M Tan, Y-S Gong, W Du, F Xu, J Ye, C-M Tang, X-W Wu, D-P Xue, S-L Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients |
| title | Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients |
| title_full | Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients |
| title_fullStr | Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients |
| title_full_unstemmed | Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients |
| title_short | Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients |
| title_sort | humanized anti-cd25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a chinese single-center experience in a group of 64 patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450331/ https://www.ncbi.nlm.nih.gov/pubmed/25885428 http://dx.doi.org/10.1038/bcj.2015.33 |
| work_keys_str_mv | AT taot humanizedanticd25monoclonalantibodytreatmentofsteroidrefractoryacutegraftversushostdiseaseachinesesinglecenterexperienceinagroupof64patients AT max humanizedanticd25monoclonalantibodytreatmentofsteroidrefractoryacutegraftversushostdiseaseachinesesinglecenterexperienceinagroupof64patients AT yangj humanizedanticd25monoclonalantibodytreatmentofsteroidrefractoryacutegraftversushostdiseaseachinesesinglecenterexperienceinagroupof64patients AT zoujy humanizedanticd25monoclonalantibodytreatmentofsteroidrefractoryacutegraftversushostdiseaseachinesesinglecenterexperienceinagroupof64patients AT jism humanizedanticd25monoclonalantibodytreatmentofsteroidrefractoryacutegraftversushostdiseaseachinesesinglecenterexperienceinagroupof64patients AT tanys humanizedanticd25monoclonalantibodytreatmentofsteroidrefractoryacutegraftversushostdiseaseachinesesinglecenterexperienceinagroupof64patients AT gongw humanizedanticd25monoclonalantibodytreatmentofsteroidrefractoryacutegraftversushostdiseaseachinesesinglecenterexperienceinagroupof64patients AT duf humanizedanticd25monoclonalantibodytreatmentofsteroidrefractoryacutegraftversushostdiseaseachinesesinglecenterexperienceinagroupof64patients AT xuj humanizedanticd25monoclonalantibodytreatmentofsteroidrefractoryacutegraftversushostdiseaseachinesesinglecenterexperienceinagroupof64patients AT yecm humanizedanticd25monoclonalantibodytreatmentofsteroidrefractoryacutegraftversushostdiseaseachinesesinglecenterexperienceinagroupof64patients AT tangxw humanizedanticd25monoclonalantibodytreatmentofsteroidrefractoryacutegraftversushostdiseaseachinesesinglecenterexperienceinagroupof64patients AT wudp humanizedanticd25monoclonalantibodytreatmentofsteroidrefractoryacutegraftversushostdiseaseachinesesinglecenterexperienceinagroupof64patients AT xuesl humanizedanticd25monoclonalantibodytreatmentofsteroidrefractoryacutegraftversushostdiseaseachinesesinglecenterexperienceinagroupof64patients |